CenterWatch

Clinical Trial Details

Overview

Research Study Summary

You may be eligible to join the EMERGE STUDY if you

Purpose
  • Are between 18 and 75 years old
  • Have been taking a stable dose of pioglitazone ≥ 30 mg/day and metformin ≥ 1,500 mg/day (or the maximum tolerated dose or maximum dose specified on the label) for at least 12 months
  • Have had no treatment with insulin for longer than 1 week during the past 6 months
  • Have weighed about the same for at least 12 weeks
  • Agree to maintain you current diet and exercise habits throughout your participation in the study

If you decide to join the study, you will be asked to:

  • Take your study medication (by injection) once a week for up to 52 weeks
  • Atted up to 11 study visits during a 1-year period and participate in a follow-up telephone visit
  • Undergo study-related procedures, including:
    • Blood draws and urine samples
    • Physical examinations (including weight and waist/hip circumference measurement
    • Vital signs (blood pressure, heart rate)
    • ECG testing
    • Glucose testing
  • Monitor your glucose levels at home
  • Maintain a study diary

To find out more and to see if you qualify, please call:

To Learn more

CW ID:156058
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
18 to 75 Years
Overall Status
Recruiting
Facility Type
N/A

Contact

Diablo Clinical Research
2255 Ygnacio Valley Rd., Suite M
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392

View Map

Research Center Information: Diablo Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.